We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WTTR:NYSESelect Water Solutions, Inc. Analysis

Data as of 2026-05-28 - not real-time

$18.14

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Select Water Solutions (WTTR) is trading at $18.14, comfortably above its 20‑day SMA of 18.21 and the 50‑day SMA of 16.50, indicating a short‑term bullish bias. The MACD histogram is negative (-0.11) and the signal line is bearish, while the RSI sits at a neutral 52.9, suggesting limited upside momentum. Q1 2026 showed a 2.3% decline in revenue to $366 million, but GAAP EPS of $0.08 beat consensus, providing a modest earnings lift. The stock’s volatility is high at 40% over the past 30 days and beta is near 1, reflecting sensitivity to broader market moves. However, the PE ratio of 86.4 dwarfs the industry average of 20.7, and the DCF‑derived fair value of $13.46 implies the market is pricing in a premium of roughly 20%. The dividend yield of 1.5% is backed by a payout ratio above 130%, raising concerns about sustainability given negative free cash flow. Analyst consensus is a “strong buy” with a median target of $21, but the fundamentals—negative revenue growth, thin operating margin (6.5%), and modest ROE (2.1%)—limit the long‑term upside. Liquidity appears moderate; volume is stable but below the 10‑day average, adding a slight liquidity risk. Overall, the stock sits at the intersection of bullish technicals and overvalued fundamentals, making the near‑term outlook cautiously optimistic while longer horizons warrant prudence.
Investors should weigh the short‑term earnings beat and bullish trend against the high valuation, weak cash generation, and sector‑specific cyclical risks. The dividend may be attractive but its sustainability is questionable, and regulatory scrutiny on water‑management services could add medium‑level risk. Given these mixed signals, a balanced stance—monitoring price action around the $16.26 support and upcoming earnings—appears prudent.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish price above short‑term SMAs
  • Neutral RSI and bearish MACD signal
  • Earnings beat despite revenue decline

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst consensus strong‑buy with $21 median target
  • Current price still below 52‑week high, offering upside
  • Positive cash flow from operations supporting near‑term growth

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • DCF fair value $13.46 suggests overvaluation
  • High PE and low ROE limit long‑term returns
  • Sustainable dividend concerns and negative free cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth-2.30%
Profit Margin1.54%
P/E Ratio86.4
ROE2.10%
ROA1.71%
Debt/Equity25.48
P/B Ratio2.4
Op. Cash Flow$230.0M
Free Cash Flow$-123207128
Industry P/E20.7

Technical Analysis

TrendBullish
RSI52.9
Support$16.26
Resistance$20.48
MA 20$18.21
MA 50$16.50
MA 200$12.39
MACDBearish
VolumeStable
Fear & Greed Index93.32

Valuation

Fair Value$13.46
Target Price$21.80
Upside/Downside20.18%
GradeOvervalued
TypeValue
Dividend Yield1.50%

Risk Assessment

Beta0.98
Volatility40.07%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.